AgriFORCE Growing Systems Ltd.

AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI; AGRIW) is an agtech company focused on building an integrated agtech platform that combines the best technology, intellectual property, and knowledge to solve an urgent problem – providing the best solutions to help drive sustainable crops and nutritious food for people around the world. The AgriFORCE vision is to be a global leader in delivering plant-based foods and products through an advanced and sustainable agtech platform that makes positive change in the world—from seed to table. Additional information about AgriFORCE is available at: www.agriforcegs.com.

CareCloud, Inc.

CareCloud offers technology solutions (a combination of software and services offering) for doctor’s offices and medical practices to drive revenue growth, workflow and operation efficiency, and transform patient experience. Its combination of software and service offerings include electronic health records, revenue cycle management, practice management, chronic care management, remote patient monitoring, business intelligence, telehealth, robotic process automation, mobile applications, workforce augmentation, and other services. Currently, ~40,000 providers leverage CareCloud solutions in 80 medical specialities.   

Nasdaq: CCLD
IR Website: https://ir.carecloud.com/
Headquarters: Somerset, NJ

Unicycive Therapeutics, Inc.

Unicycive Therapeutics is a biopharma company with development programs focused on two kidney diseases with largely unmet medical needs. 

Nasdaq: UNCY
IR Website: https://ir.unicycive.com/
Headquarters: Los Altos, CA

It is developing Renazorb* (lanthanum dioxycarbonate) an investigational phosphate binding agent using proprietary nanoparticle technology for the treatment of patients with hyperphosphatemia. They are also developing UNI-494, a novel new chemical entity that targets mitochondrial dysfunction which is in late preclinical development for the treatment of acute kidney injury.

Agilyx

Agilyx, founded in 2004, is a leader in chemical plastics recycling solutions, positioned to solve and mitigate the global challenge of plastic waste. The company has developed a patented, flexible, commercially validated and scalable solution to convert waste plastic into recycled materials and products in a massive yet untapped market. With Cyclyx, a JV with ExxonMobil, Agilyx possesses the industry know-how of feedstock supply and management. Being a technology enabler that deploys an asset light model, Agilyx can scale many projects simultaneously and rapidly. ExxonMobil, Virgin, Mitsubishi Chemical and Technip Energies are several selected key partners of the company.

OTCQX: AGXXF
OSE: AGLX
IR Website: agilyx.com/investors
Headquarters: Portsmouth, New Hampshire

Agrify

Agrify is a leading provider of innovative cultivation and extraction solutions for the cannabis industry, bringing data, science, and technology to the forefront of the market. Our proprietary micro-environment-controlled Vertical Farming Units (VFUs) enable cultivators to produce the highest quality products with unmatched consistency, yield, and ROI at scale. Our comprehensive extraction product line, which includes hydrocarbon, ethanol, solventless, post-processing, and lab equipment, empowers producers to maximize the quantity and quality of extract required for premium concentrates. For more information, please visit Agrify at http://www.agrify.com.

Electrovaya Inc.

Electrovaya Inc. (TSX:EFL) (OTCQB:EFLVF) is a pioneering leader in the global energy transformation, focused on contributing to the prevention of climate change by supplying safe and long-lasting lithium-ion batteries without compromising energy and power.. Electrovaya is a technology-focused company with extensive IP, designs, develops, and manufactures proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation, and other specialized applications. To learn more about how Electrovaya is powering mobility and energy storage, please explore www.electrovaya.com.

Lantern Pharma Inc.

Lantern Pharma is a clinical stage biotechnology company focused on innovating the cancer drug development process by using advanced genomics, machine learning, and artificial intelligence ("A.I."). Our A.I. platform, known as RADR®️, currently includes more than 25 billion data points, and uses big data analytics and machine learning to rapidly uncover biologically relevant genomic signatures correlated to drug response, and then to identify the cancer patients that we believe may benefit most from our compounds. RADR®️ is also used by Lantern and its collaborators to 1) develop and position new drugs and 2) to rescue and reposition drug candidates that others have tried, but failed, to develop.

Lantern’s current portfolio consists of four drug candidates and an ADC program across twelve disclosed tumor targets, including two Phase 2 programs and several additional Phase 1 clinical trials anticipated for 2023. Lantern seeks out experienced industry partners, world-class scientific advisors and innovative clinical-regulatory approaches to assist with its objective of delivering cancer therapies to patients as quickly and cost-effectively as possible. This data-driven, genomically-targeted and biomarker-driven approach allows us to pursue a transformational drug development strategy that identifies, rescues or develops, and advances potential small molecule drug candidates at what we believe is a fraction of the time and cost associated with traditional cancer drug development.

Cantargia AB

Cantargia is a clinical stage company developing novel therapies for both cancer and autoimmune/inflammatory disease. The lead program nadunolimab has generated positive interim results during treatment of pancreatic cancer, lung cancer and triple negative breast cancer. The development is now focusing on ongoing or upcoming randomized clinical trials in these diseases. The second program, CAN10, has shown potent activity in a number of models of autoimmune or inflammatory diseases and is entering phase I clinical development and the development is targeting myocarditis and systemic sclerosis. Cantargia is listed on NASDAQ Stockholm.

CEL-SCI Corporation

CEL-SCI Corporation (NYSE American: CVM) is a biotechnology company with the mission to improve the treatment of cancer and other diseases by utilizing the immune system. We completed a global pivotal Phase 3 study in head and neck cancer and reported data showing a significant survival benefit with no toxicity added in patients with advanced primary squamous cell carcinoma of the head and neck (SCCHN) who received its Multikine® immunotherapy prior to a standard of care (SOC) treatment of surgery plus radiotherapy as compared to patients who received SOC alone. Data from the Phase 3 study have been presented at the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO) annual meetings in 2022. CEL-SCI is preparing to file a Biologic License Application (BLA) with the U.S. Food and Drug Administration (FDA) for approval and Multikine has received Orphan Drug designation from the FDA for this indication, SCCHN. The commercial scale buildout of its cGMP manufacturing facility is complete, and CEL-SCI is preparing it for inspection by the FDA in advance of Multikine’s commercial launch, pending FDA approval of the BLA.

Salem Media Group, Inc.

Salem Media Group is America’s leading multimedia company specializing in Christian and conservative content, with media properties comprising radio, digital media and book and newsletter publishing. Each day Salem serves a loyal and dedicated audience of listeners and readers numbering in the millions nationally. With its unique programming focus, Salem provides compelling content, fresh commentary and relevant information from some of the most respected figures across the Christian and conservative media landscape. Learn more about Salem Media Group, Inc. at www.salemmedia.com, Facebook and Twitter.

Amprius Technologies

Amprius Technologies is at the forefront of transforming electric mobility with its revolutionary silicon anode lithium-ion battery. Its commercially proven batteries deliver unmatched performance – ultra-high energy density, high power density, extreme fast-charge rate capability, wide operating temperature, and long cycle life – required for aviation, aerospace, defense, and electric vehicles (EV). The company’s corporate headquarters is in Fremont, California, where it maintains an R&D lab and a pilot manufacturing facility.

Reliance Global Group, Inc.

Reliance Global Group, Inc. (NASDAQ: RELI, RELIW) an InsurTech pioneer, is working to transform the traditional insurance agency model by combining artificial intelligence (AI) with the personalized experience of a traditional insurance agency model. Reliance Global Group’s growth strategy includes the organic expansion of its current portfolio of agencies owned in addition to the growth of 5MinuteInsure.com, its online business-to-consumer platform that utilizes artificial intelligence and data mining, to provide competitive insurance quotes within 5 minutes, and RELI Exchange, its B2B InsurTech platform and agency partner network for insurance agents and agencies, designed to give independent agents an entire suite of business development tools and the ability to effectively compete with national agencies. Additional information about the Company is available at relianceglobalgroup.com.

FiscalNote

FiscalNote is the leading technology provider of global policy and market intelligence. By uniquely combining AI technology, actionable data, and expert and peer insights, FiscalNote empowers customers with mission-critical insights and the tools to turn them into action.

We believe that leveraging technology is the key to providing transparency into the policy, people, and geopolitics shaping today’s world. Our technology sustains products and services that power clients around the world -- from small nonprofits to government agencies to large corporations (including more than half of the Fortune 100) -- with patented technology, expert analysis, and AI-powered data. Although our team and products have evolved significantly over time, we’ve never wavered from our north star to deliver novel, innovative, and compelling solutions to meet today’s most pressing challenges.

Home to CQ, FrontierView, Oxford Analytica, VoterVoice, and many other industry-leading brands, FiscalNote helps organizations stay ahead of rapidly evolving political, corporate, and regulatory environments.

Graphex Group Limited

Graphex Group Limited is a Cayman Island company with principal and administrative offices in Hong Kong and subsidiary office in Royal Oak, MI. Graphex is a global leader in the industry focused on the development of technologies and products for the enhancement of renewable energy, particularly the enrichment of spherical graphite and graphene, key components for Electric Vehicle (EV) batteries, Lithium-ion batteries, and other use cases. Proficient in commercial deep processing of graphite, Graphex has been consistently producing over 10,000 metric tons of spherical graphite annually for over 9 years. With a strategy to expand its global operations to support energy transition and electrification efforts worldwide, Graphex Group is currently among the top suppliers of specialized spherical graphite to the EV and renewable energy industries and holds patents in areas including products, production methods, machinery design, and environmental protection.

Orgenesis Inc.

Orgenesis is a global biotech company working to unlock the full potential of cell and gene therapies (CGTs) in an affordable and accessible format at the point of care. The Orgenesis POCare Platform is comprised of three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. Orgenesis identifies promising new therapies and leverages its POCare Platform to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production. The POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals worldwide to achieve harmonized, regulated clinical development and production of the therapies. www.orgenesis.com.

Innoviva

Innoviva is a diversified biopharmaceutical company with a portfolio of royalties and a growing portfolio of innovative healthcare assets

• Royalty portfolio consists of respiratory products that were jointly developed with, and are licensed to, GSK and collectively make up a large portion of GSK’s leading respiratory franchise (RELVAR®/ BREO® ELLIPTA®, ANORO® ELLIPTA®)

• Integrated hospital / infectious disease business formed via recent acquisitions of Entasis Therapeutics and La Jolla Pharmaceutical companies with strong growth prospects and significant operating leverage

• Strategic healthcare assets in areas with high unmet medical need and significant long-term value creation potential, including a majority stake in bacteriophage leader Armata Pharmaceuticals

Pasithea Therapeutics

Pasithea Therapeutics is a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system (CNS) disorders.

Stran & Company, Inc.

Over the past 27 years, Stran has grown to become a leader in the promotional products industry, specializing in complex marketing programs to help recognize the value of promotional products, branded merchandise, and loyalty incentive programs as a tool to drive awareness, build brands and impact sales. Stran is the chosen promotional programs manager of many Fortune 500 companies, across a variety of industries, to execute their promotional marketing, loyalty and incentive, sponsorship activation, recruitment, retention, and wellness campaigns. Stran provides world-class customer service and utilizes cutting-edge technology, including efficient ordering and logistics technology to provide order processing, warehousing and fulfillment functions. The Company’s mission is to develop long-term relationships with its clients, enabling them to connect with both their customers and employees in order to build lasting brand loyalty. Additional information about the Company is available at: www.stran.com.

Spok, Inc.

Spok, Inc. is proud to be a global leader in delivering clinical communications to healthcare providers. Organizations rely on Spok for its contact center optimization solutions, web directory, secure texting, workflow improvement, and paging services, among other services. Spok has the largest installed base of pagers in the U.S. – over 800,000 – and provides centralized communication solutions to over 2,200 hospitals. Top hospitals rely on the Spok Care Connect® platform to enhance workflows for clinicians and support administrative compliance.

Spok, Inc., is a wholly owned subsidiary of Spok Holdings, Inc.
NASDAQ: SPOK
Headquarters: Alexandria, Virginia
www.spok.com

Lexaria Bioscience Corp.

Lexaria Bioscience Corp.'s patented drug delivery technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 28 patents granted and many patents pending worldwide. For more information, please visit www.lexariabioscience.com.

Limbach Holdings, Inc.

Limbach is a building systems solutions firm with expertise in the design, prefabrication, installation, management and maintenance of heating, ventilation, air-conditioning ("HVAC"), mechanical, electrical, plumbing and controls systems. With over 1,500 team members and 17 offices located throughout the United States, we partner with institutions with mission-critical infrastructures, such as data centers and healthcare, industrial & light manufacturing, cultural & entertainment, higher education, and life science facilities. With Limbach's full life-cycle capabilities, from concept design and engineering through system commissioning and recurring 24/7 service and maintenance, Limbach is positioned as a value-added and indispensable partner for building owners, construction managers, general contractors, and energy service companies.

Alamo Group, Inc.

Alamo Group is a leader in the design, manufacture, distribution, and service of high-quality equipment for vegetation management, infrastructure maintenance and other applications. Our products include truck and tractor mounted mowing and other vegetation maintenance equipment, street sweepers, snow removal equipment, excavators, vacuum trucks, forestry and tree care equipment, and related after-market parts and services. The Company, founded in 1969, has approximately 4,200 employees and operates 28 manufacturing plants in North America, Europe, Australia, and Brazil. The corporate offices of Alamo Group Inc. are located in Seguin, Texas.

Onfolio Holdings Inc.

Onfolio acquires and manages profitable small online businesses, ranging from marketing agencies, to online courses, to wordpress software. Management finds businesses which are already successful and augments what is working, while adding more to the business. They operate in a target-rich environment giving a large opportunity to take advantage of the mis-pricings among small online businesses

Orion Office REIT, Inc.

Orion Office REIT Inc. (NYSE: ONL) is an internally-managed real estate investment trust engaged in the ownership, acquisition and management of a diversified portfolio of mission-critical and headquarters office buildings located in high-quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy tenants. The company was founded on July 1, 2021, spun-off from Realty Income (NYSE: O) on November 12, 2021 and began trading on the New York Stock Exchange on November 15, 2021. The company is headquartered in Phoenix, Arizona and has an office in New York, New York. For additional information on the company and its properties, please visit onlreit.com.

Treasure Global, Inc.

Treasure Global Inc (“TGI”) is an innovative Malaysian e-commerce platform providing seamless technology enabled solutions for lifestyle needs with instant rebates and affiliate cashback programs. On a mission to bring together the worlds of online e-commerce and offline physical retailers, TGI is developing a portfolio of leading digital platforms for use throughout Southeast Asia (“SEA”) and Japan. In June 2020, TGI launched its proprietary product, the ZCITY App, a unique digital ecosystem that transforms and simplifies the e-payment experience for consumers, while simultaneously allowing them to earn rewards. In the ZCITY ecosystem, users can utilize TAZTE, a revenue generating digital F&B management system providing merchants with a one-stop touchless management and automated solution to digitalize their businesses.

For more information, please visit https://treasureglobal.co/. 

Open Locker, Inc.

Openlocker Holdings is a technology platform for athletes and brands to redefine and unlock consumer and fan value. Openlocker builds highly engaged fan communities on the Blockchain primarily for colleges and universities using student-athletes Name, Image and Likeness (N.I.L.) opening the door to countless revenue opportunities that previously did not exist. OpenLocker increases engagement among fans, athletes and brands through digital and physical collectibles and provides unique user utility, perks and experiences. 

BioVie, Inc.

BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing innovative therapies to overcome unmet medical needs in chronic debilitating conditions. In neurodegenerative disease, the Company’s drug candidate NE3107 inhibits inflammatory activation of ERK and NFkB (e.g., TNF signaling) that leads to neuroinflammation and insulin resistance, but not their homeostatic functions (e.g., insulin signaling and neuron growth and survival). Both are drivers of Alzheimer’s and Parkinson’s diseases. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients with mild to moderate Alzheimer's disease (NCT04669028) and is targeting primary completion in 3rd quarter of 2023. An estimated six million Americans suffer from Alzheimer’s. A Phase 2 study of NE3107 in Parkinson’s disease (NCT05083260) has completed and provided its topline data readout in December 2022. In liver disease, the Company’s Orphan drug candidate BIV201 (continuous infusion terlipressin), with FDA Fast Track status, is being evaluated in a US Phase 2b study for the treatment of refractory ascites due to liver cirrhosis with top-line results anticipated in mid-2023. BIV201 is administered as a patent-pending liquid formulation. The active agent is approved in the U.S. and in about 40 countries for related complications of advanced liver cirrhosis.  For more information, visit http://www.bioviepharma.com/.

OneMedNet

OneMedNet unlocks the significant value contained within the clinical image archives of healthcare providers by transforming Real-World Data into a valuable, quality asset that can help clinicians improve care and lower costs. Employing its proven OneMedNet iRWD™ solution, OneMedNet securely de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with industry leading technology and in-house clinical expertise, OneMedNet successfully meets the most rigorous Real-World Data Life Science requirements.

Hyster-Yale Materials Handling, Inc.

Hyster-Yale Materials Handling, Inc. (NYSE:HY), through its wholly-owned operating subsidiary, Hyster-Yale Group, Inc., designs, engineers, manufactures, sells and services a comprehensive line of lift trucks and aftermarket parts marketed globally primarily under the Hyster® and Yale® brand names. Hyster-Yale Group has been building relationships and partnering with customers, suppliers, dealers, and employees for over 90 years. Subsidiaries of Hyster-Yale Group include Bolzoni S.p.A., a leading worldwide producer of attachments, forks and lift tables marketed under the Bolzoni®, Auramo® and Meyer® brand names, and Nuvera Fuel Cells, LLC, an alternative-power technology company focused on fuel cell stacks and engines. Hyster-Yale Group also has an unconsolidated joint venture in Japan (Sumitomo NACCO).

Global material handling customers are facing unprecedented challenges, such as labor shortages, heightened safety concerns, higher operating costs and expanding clean-energy mandates. Hyster-Yale is dedicated to solving these challenges by delivering tailored forklift, attachment and fuel cell solutions through our portfolio of exceptional brands. The Hyster® brand is focused on industrial applications. Yale® Lift Truck Technologies provides solutions for demanding warehousing applications. The Maximal brand provides high-value, cost-effective trucks for customers requiring fundamental lift truck performance. The Sumitomo-NACCO brand provides solutions optimized for Japanese quality and customers. Bolzoni’s attachments help to move products in manner that protects the contents, while enhancing productivity. Nuvera develops advanced hydrogen technologies and manufactures them into robust clean power products for motive and stationary applications.

Portage Biotech

Portage is a clinical-stage immuno-oncology company advancing multi-targeted therapies to extend survival and significantly improve the lives of patients with cancer. Lead programs in the Portage portfolio include first-in-class invariant natural killer T cell small molecule engagers and best-in-class adenosine antagonists. These programs are being advanced using innovative trial designs and translational data to identify the patient populations most likely to benefit from treatment. The Company’s unique business model leverages a strong network of academic experts and large pharma partners to rapidly and efficiently advance multiple products.

BurgerFi

Everyone's fanatical about something. At BurgerFi we're Finatical about delivering burgers from all-natural Angus Beef, free of steroids, additives and hormones, loaded with uncompromising flavors from the highest quality ingredients. Yes, we are Burger Finatics and we know you are too.

BioMea Fusion

Biomea Fusion is a clinical stage biopharmaceutical company focused on the discovery and development of covalent small molecules to treat patients with genetically defined cancers and metabolic diseases. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein and offers a number of potential advantages over conventional non-covalent drugs, including greater target selectivity, lower drug exposure, and the ability to drive adeeper, more durable response. The company is utilizing its proprietary FUSION™ System to advance a pipeline of covalent-binding therapeutic agents against key oncogenic drivers of cancer and metabolic diseases. Biomea Fusion’s goal is to utilize its capabilities and platform to become a leader in developing covalent small molecules in order to maximize the clinical benefit when treating various cancers and metabolic diseases.

Odyssey Marin Exploration, Inc.

Odyssey Marine Exploration, Inc. (Nasdaq: OMEX) is a deep-ocean exploration pioneer engaged in the discovery, validation, and development of subsea mineral resources. The company focuses on exploring polymetallic nodules (battery metals to power the future) and subsea phosphate deposits (fertilizer to feed the future), which we believe will benefit society now and in the future. The company provides marine services for private clients and governments interested in exploring their Exclusive Economic Zones to survey, map, and identify potential mineral resources and has several projects in various stages of development worldwide. Odyssey’s projects are developed with partners who share our commitment to sustainable and environmentally sound solutions. For additional details, please visit www.odysseymarine.com.

Massivit 3D Printing Technologies

Massivit 3D Printing Technologies Ltd. www.massivit3d.com (Tel Aviv Stock Exchange: MSVT) is a leading provider of industrial 3D printing systems for the automotive, marine, railway, and additional markets. The company’s solutions enable cost-effective production of large parts, molds, and prototypes at unprecedented speed. Massivit’s vision is to transform manufacturing of large parts from traditional processes to ultra-fast, digital fabrication using industrial-grade materials. The company was founded in 2013 by a team of experts led by Gershon Miller – founder of Objet Geometry. Massivit’s headquarters are based in Lod, Israel with regional NA and EMEA offices in Atlanta, Georgia and Belgium. The company provides its worldwide community with end-to-end services supported through an extensive dealer network.

Selina

Selina (NASDAQ: SLNA) is one of the world's fast-growing hospitality companies built to address the needs of millennial and Gen Z travelers, blending beautifully designed accommodation with coworking, recreation, wellness, and local experiences. Founded in 2014 and custom-built for today's nomadic traveler, Selina provides guests with a global infrastructure to seamlessly travel and work abroad. Each Selina property is designed in partnership with local artists, creators, and tastemakers, breathing new life into existing buildings in 24 countries and six continents – from urban cities to remote beaches and jungles. To learn more, visit Selina.com or follow Selina on Twitter, Instagram, Facebook or YouTube. 

agenus

Agenus is a clinical-stage biopharmaceutical company that discovers, manufactures, and develops immunotherapies for cancer. Our portfolio consists of bio-engineered therapies designed to activate the body’s own defenses in order to fight cancer. These therapies are optimized through an integrated, proprietary active learning platform designed to deliver better drugs, optimized combinations, and predictive biomarkers to address critical unmet needs in cancer.

Strata Skin Sciences

STRATA Skin Sciences is a medical technology company focused on the therapeutic and aesthetic dermatology market. Its products include the XTRAC® laser, VTRAC® excimer lamp, and TheraClear®X systems utilized in the treatment of psoriasis, vitiligo, acne and various other skin conditions.

E.C.D Automotive Design

E.C.D. Automotive Design (E.C.D.) is a creator of restored luxury vehicles that combines classic English beauty with modern performance. Each vehicle produced by E.C.D. is fully bespoke, a one-off that is designed by the client through an immersive luxury design experience and hand-built from the ground up in 2,200 hours by master-certified ASE craftsmen. The company was founded in 2013 by three British “petrol heads” whose passion for classic vehicles is the driving force behind exceptionally high standards for quality, custom luxury vehicles. E.C.D.’s global headquarters, known as the “Rover Dome,” is a 100,000 square-foot purpose-built facility located in Kissimmee, Florida that is home to 60 talented craftsman and technicians, who hold a combined 61 ASE and five master-level certifications. E.C.D. has a logistics center in the U.K. that sources and transports 25-year-old work vehicles back to the U.S. for restoration. The vehicle produces custom one-of-one luxury-class British vehicles for high net-worth individuals. It has transformed the cottage industry into a scalable disciplined custom automotive restorer by putting the client at the center of the design experience & allocated autonomy to skilled team members to handcraft each product. With five hundred vehicles built to date & a CAGR of 26%, ECD is the leader in the ever-growing restoration market. ECD pioneered the combination of classic restoration with electrification & proudly owns the title of the world's first Electric Powered Land Rover Defender. 

Learn more at www.ecdautodesign.com

TETRA Technologies, Inc.

TETRA Technologies, Inc. is an energy services and solutions company operating on six continents with a focus on bromine-based completion fluids, calcium chloride, water management solutions, frac flowback, and production well testing services. Calcium chloride is used in the oil and gas, industrial, agricultural, road, food, and beverage markets. TETRA is evolving its business model by expanding into the low carbon energy markets with its chemistry expertise, key mineral acreage, and global infrastructure. Low carbon energy initiatives include commercialization of TETRA PureFlow^®, an ultra-pure zinc bromide clear brine fluid for stationary batteries and energy storage; advancing an innovative carbon capture utilization and storage technology with CarbonFree to capture CO₂ and mineralize emissions to make commercial, carbon-negative chemicals; and development of TETRA's lithium and bromine mineral acreage to meet the growing demand for oil and gas products and energy storage. Visit the Company's website at www.tetratec.com for more information.

Jupiter Wellness, Inc.

Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (OTC) products and intellectual property. The Company’s product pipeline addresses a range of conditions, including hair loss, psoriasis, and vitiligo. Revenue is generated through the sales of OTC and consumer products and licensing royalties.

Snail, Inc.

We are a leading, global independent developer and publisher of interactive digital entertainment for consumers around the world. Our mission is to provide high-quality interactive entertainment to our global audience. Our expertise in technology, in-game ecosystems and monetization of online multiplayer games has enabled us to assemble a broad portfolio of intellectual properties. We have built a portfolio of premium games across platforms, including consoles, PCs, and mobile devices.  Our flagship franchise, ARK: Survival Evolved, is a leader within the sandbox survival genre with over 84.7 million console and PC installs through December 31, 2022.

Gaucho Group Holdings, Inc.

For more than ten years, Gaucho Group Holdings, Inc.’s (gauchoholdings.com) mission has been to source and develop opportunities in Argentina's undervalued luxury real estate and consumer marketplace. Our company has positioned itself to take advantage of the continued and fast growth of global e-commerce across multiple market sectors, with the goal of becoming a leader in diversified luxury goods and experiences in sought after lifestyle industries and retail landscapes. With a concentration on fine wines (algodonfinewines.com & algodonwines.com.ar), hospitality (algodonhotels.com), and luxury real estate (algodonwineestates.com) associated with our proprietary Algodon brand, as well as the leather goods, ready-to-wear and accessories of the fashion brand Gaucho – Buenos Aires™ (gaucho.com), these are the luxury brands in which Argentina finds its contemporary expression.